Targeting IL-1β: a potential strategy for alleviating the immunopathology of aortic aneurysms. [PDF]
Front ImmunolZhang F, Liao Y, Zhao D, Guo J.
europepmc +1 more source
Pharmacological and non-pharmacological treatments for refractory paediatric Still's disease: a scoping review. [PDF]
Rheumatol Adv PractTwynam-Perkins E, Martin N, McLellan K.
europepmc +1 more source
Advances in the management of gout: From current strategies to emerging therapies. [PDF]
J Int Med ResZhao Q, Dai X.
europepmc +1 more source
Pediatric rheumatic diseases and vaccinations: a promising alliance. [PDF]
Front PediatrCorsello G +4 more
europepmc +1 more source
The effect of IL-1 blockers on exertional leg pain in familial Mediterranean fever patients: an exploratory study. [PDF]
Rheumatology (Oxford)Druyan A +4 more
europepmc +1 more source
Canakinumab treatment in patients with colchicine-resistant familial mediterranean fever: a multicenter observational study. [PDF]
Turk J Med SciKoç E, Pekdiker M, Kara M.
europepmc +1 more source
IL-1β Pathway Inhibition in Asthma and COPD: Strong Biological Rationale, Disappointing Clinical Trials, and Emerging New Opportunities. [PDF]
LungCazzola M, Page CP, Matera MG.
europepmc +1 more source
Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review. [PDF]
Paediatr DrugsIsa M, Tiller GM, Liew DFL, Renton WD.
europepmc +1 more source
Comparative effectiveness and safety of systemic therapies for treatment-naïve, PD-L1 expression <1% advanced NSCLC: a systematic review and network meta-analysis. [PDF]
Transl Lung Cancer ResZhou M +10 more
europepmc +1 more source
Targeted Anti-Inflammatory Therapy in Cardiovascular Events: Challenges and Opportunities. [PDF]
J Clin Hypertens (Greenwich)Ma T, Wang L, Yan X, Li F.
europepmc +1 more source